D-0577-2020 Class II Terminated
FDA drug recall D-0577-2020 was initiated by Pfizer Inc. on November 27, 2019 and is designated Class II. Reason for recall: Labeling: Incorrect or Missing Lot and/or expiration date. The recall status is terminated (terminated January 14, 2022). Affected quantity: 77,100 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- December 18, 2019
- Initiation Date
- November 27, 2019
- Termination Date
- January 14, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 77,100 syringes
Product Description
25% Dextrose Injection, USP 2.5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1775-10
Reason for Recall
Labeling: Incorrect or Missing Lot and/or expiration date.
Distribution Pattern
Nationwide within the United States including Puerto Rico.
Code Information
Lot #: 80-292-EV, 1AUG2019 on carton. Expiration date printed on syringe is 1AUG2021 which is incorrect.